干扰素α治疗慢性病毒性肝炎中干扰素受体调节的作用
被引量：2
摘要
目前，在慢性病毒性肝琰治疗中IFN具有重要作用，其抗病毒和免疫调节效应的发挥是通过与细胞表面特异性受体结合，从而激活一系列胞内信号转导机制。作为关键环节的受体，其活性并非一成不变，而是处于动态平衡中，既遵循一定的规律进行新陈代谢，同时又可受各种生理、药物、病理等因素的变化而调节。在IFN治疗过程中，IFN受体调节对治疗效果可产生重要影响。
出处
《中华传染病杂志》
CAS
CSCD
北大核心
2007年第1期57-58,共2页
Chinese Journal of Infectious Diseases
参考文献16
-
1Biron CA. Interferons alpha and beta as immune regulators -a newlook. Immunity, 2001, 14:661-664.
-
2Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex. Nat Immunol, 2003, 4:69-77.
-
3Platanias LC. Mechanisms of type- Ⅰ -and type- Ⅱ -interferonmediated signalling. Nat Rev Immunol, 2005, 5:375-386.
-
4Maxwell BL, Talpaz M, Gutterman JU. Down-regulation of peripheral blood cell interferon receptors in chronic myelogenous leukemia patients undergoing human interferon (HuIFNalpha) therapy. Int J Cancer, 1985, 36:23-28.
-
5Nakajima S, Kuroki T, Shintani M, et al. Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon.Hepatology, 1990, 12 : 1261-1265.
-
6Fierlbeck G, Ulmer A, Schreiner T, et al. Pharmacodynamics of recombinant IFN-beta during long-term treatment of malignant melanoma. J Interferon Cytokine Res, 1996, 16:777-781.
-
7Kumar KG, Tang W, Ravindranath AK, et al. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J, 2003, 22: 5480-5490.
-
8Yatsuhashi H, Fujino T, Matsumoto T, et al. Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol, 1999, 30:995-1003.
-
9Fujiwara D, Hino K, Yamaguchi Y, et al. Type Ⅰ interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study. J Viral Hepat, 2004, 11: 136-140.
-
10Massirer KB, Hirata MH, Silva AE, et al. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C. Braz J Med Biol Res, 2004,37: 643-647.
同被引文献8
-
1Biron CA. Interferons alpha and beta as immune regulators-a new look. Immunity, 2001, 14: 661-664.
-
2Platanias LC. Mechanisms of type-Ⅰ- and type-Ⅱ-interferon-mediated signalling. Nat Rev Immunol, 2005, 5: 375-386.
-
3Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex. Nat Immunol, 2003, 4: 69-77.
-
4Marcellin P. Advances in therapy for chronic hepatitis B. Semin Liver Dis, 2002, 22 Suppl 1 : 33-36.
-
5Liaw YF. Therapy of chronic hepatitis B: current challenges and opportunities. J Viral Hepat, 2002, 9: 393-399.
-
6王玉华,赵鸿,韩忠厚,曹丽华,陈爱君,赵雅君,彭勋,马万林.干扰素治疗慢性乙型肝炎患者血清HBV DNA动态变化及其意义[J].中华传染病杂志,2007,25(10):631-632. 被引量：3
-
7中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量：14012
-
8徐勇,黄仁魏.聚乙二醇化干扰素治疗慢性粒细胞白血病临床应用研究进展[J].新医学,2004,35(4):251-252. 被引量：2
引证文献2
-
1陈宪锐,王会亮,玄梅香,毛新刚,孙建国,万宝美.干扰素中和抗体对干扰素治疗慢性乙型肝炎效果的影响[J].中华肝脏病杂志,2009,17(5):385-386. 被引量：2
-
2赵辉,金涛,徐海萍.干扰素α治疗骨髓增殖性肿瘤的给药间隔临床研究[J].中国医药指南,2014,12(23):173-174.
二级引证文献2
-
1贾敏,王立清,段瑾,陈曦,盛艾娟,王美霞,吕秋军,徐静,王宝亮,梁屹.重组高效抗肿瘤抗病毒蛋白注射液治疗慢性乙型肝炎受试者后血清中和抗体检测[J].首都医药,2014,21(18):50-52.
-
2吴颖颖,欧启水.预测IFN治疗慢性乙型肝炎疗效的实验室指标研究进展[J].临床检验杂志,2015,33(8):608-611.
-
1李艳芳,张献,刘国树.心脏环磷酸腺苷和环磷酸鸟苷的受体调节及其交互作用[J].中国循环杂志,2002,17(3):238-240. 被引量：20
-
2常雅萍,姜顺爱,杨贵贞.杏仁核在实验性变态反应性脑脊髓炎模型鼠的免疫调节效应[J].中国免疫学杂志,1993,9(4):222-222. 被引量：1
-
3郭勇.合理运用皮质激素[J].黑龙江医药,2008,21(1):82-82.
-
4王玲,张才军,李维波,蒋绿芝,谢蒲伶,邓学端.枸杞多糖对2型糖尿病患者T淋巴细胞亚群和细胞因子的调节作用[J].河北中医,2001,23(12):888-890. 被引量：18
-
5陈彦波,吴移谋.Th17细胞在衣原体感染中的作用研究[J].微生物学免疫学进展,2015,43(2):45-48. 被引量：2
-
6怎样防治化疗引起的胃肠道反应?[J].上海预防医学,2003,15(7):341-341.
-
7罗春燕.饮食习惯并非一成不变[J].糖尿病天地,2008(6):54-57.
-
8孙致连,叶山东.炎症因子与糖尿病肾病关系的研究进展[J].国际病理科学与临床杂志,2008,28(4):366-368. 被引量：8
-
9杨国平,黎明涛,张寄南,杨笛,马文珠,王敬良.肾性高血压大鼠心、肾α_1肾上腺素能受体的变化[J].中华高血压杂志,1994,12(3):137-139.
-
10冯璇,臧伟进,周筠.迷走神经在心律失常发生中的研究进展[J].心脏杂志,2012,24(5):646-650. 被引量：4
